PJ

Pankti Jyotendra Lodhawala

Active Director Director DIN 09165961
DIN 09165961 First appointment Mar 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Pankti Jyotendra Lodhawala

Data last updated:

Pankti Jyotendra Lodhawala is a Director at Pharma Fill Limited (since 2021). The company operates in Pharma.

DIN 09165961
Primary Designation Director
Industry Pharma
First Appointment 22 Mar 2021
Oldest Company Age 44 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharma Fill Limited U24239MH1982PLC026299
Director22 Mar 20211982Active

Board colleagues of Pankti Jyotendra Lodhawala

NameDINCompanyDesignation
Ashokbhai Jashbhai Patel09110114Pharma Fill LimitedDirector
Thelma Cardoz08118678Pharma Fill LimitedDirector

Directorship timeline

Open interactive timeline →
Pharma Fill Limited
Premium access

Shareholding and investment profile for Pankti Jyotendra Lodhawala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pankti Jyotendra Lodhawala

Pankti Jyotendra Lodhawala currently holds 1 directorship: Pharma Fill Limited (Director, since 22 Mar 2021).

Pankti Jyotendra Lodhawala was first appointed on 22 Mar 2021 as Director at Pharma Fill Limited.

The current boards of Pankti Jyotendra Lodhawala's companies include Ashokbhai Jashbhai Patel (Pharma Fill Limited), Thelma Cardoz (Pharma Fill Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available